THE NATURE OF OUR BUSINESS – STABLE GROWTH - Symrise
THE NATURE OF OUR BUSINESS – STABLE GROWTH - Symrise
THE NATURE OF OUR BUSINESS – STABLE GROWTH - Symrise
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
7. EARNINGS PER SHARE<br />
Basic undiluted earnings per share are calculated by dividing the<br />
profit for the year attributable to the holders of the parent company’s<br />
ordinary shares by the average number of ordinary shares<br />
outstanding during the year.<br />
No option or conversion rights were issued either in 2008 or 2007,<br />
so that the diluted and basic undiluted results are identical.<br />
Earnings per share in €<br />
Weighted average number of ordinary<br />
shares, in thousands<br />
8. CONSOLIDATED BALANCE SHEET<br />
8.1.Cash and Cash Equivalents<br />
T€<br />
Cash<br />
Cash equivalents<br />
Cash and cash equivalents<br />
Bank balances in the Group’s key currencies earn interest at variable<br />
rates of up to 7.0% (2007: between 3.0% and 6.0%). The carrying<br />
amounts for cash and cash equivalents correspond to their<br />
fair value.<br />
8.2.Trade Receivables<br />
T€<br />
Trade receivables<br />
Less: Provision for doubtful accounts<br />
Trade receivables, net<br />
2007<br />
0.82<br />
118,173<br />
2007<br />
78,991<br />
259<br />
79,250<br />
2007<br />
218,625<br />
-4,147<br />
214,478<br />
2008<br />
0.76<br />
118,173<br />
2008<br />
68,664<br />
196<br />
68,860<br />
2008<br />
224,007<br />
-2,321<br />
221,686<br />
The risk of default for trade receivables is limited due to the large<br />
number of customers and their widely diversified activities in different<br />
markets. In view of this, management believes that the risk<br />
has been appropriately measured. Any allowances for bad debts<br />
are mainly based on an individual assessment of the default risk.<br />
The carrying amount of trade receivables corresponds to their fair<br />
value.<br />
8.3.Derivative Financial Instruments<br />
Derivative financial instruments are recognized as assets or liabilities<br />
at their fair value.<br />
Financial instruments held<br />
for trading<br />
Interest rate swaps T€<br />
Interest rate swaps TUS$<br />
Balance Sheet Presentation<br />
T€<br />
Prepayments, other assets<br />
and receivables current<br />
Other assets noncurrent<br />
Other current liabilities<br />
(Point 8.17)<br />
Other noncurrent liabilities<br />
(Point 8.18)<br />
Net receivables from derivatives<br />
and liabilities<br />
Face Value<br />
2007 2008<br />
480,000<br />
75,000<br />
760,000<br />
265,000<br />
Carrying<br />
amount<br />
2007<br />
1,251<br />
9,301<br />
Derivative financial instruments with a nominal value of € 380 million<br />
(2007: € 100 million) and $ 90 million (2007: $ 75 million)<br />
have a term to maturity of less than one year.<br />
The nominal value of derivative financial instruments with a term<br />
to maturity of between one and five years amounted to € 380 million<br />
and $ 175 million (2007: € 531 million).<br />
Cash Flow Hedges<br />
The Group has designated cash flow hedges related to the hedging<br />
of interest risks. The hedged item consists of borrowings that<br />
form part of an overall credit facility amounting to € 800 million,<br />
which has a term until December 13, 2011.<br />
As a result of contracted plain vanilla payer interest swaps, <strong>Symrise</strong><br />
is charged variable interest by its bank trading partner and<br />
pays a fixed interest rate in return. This interest rate is fixed over<br />
the term of the swap and eliminates the risk of fluctuating cash<br />
flows, which would result from the variable interest bearing liabilities<br />
that have been designated as the hedged item.<br />
0<br />
0<br />
10,552<br />
Fair value<br />
2007 2008<br />
10,366<br />
273<br />
-9,089<br />
-8,117<br />
Carrying<br />
amount<br />
2008<br />
0<br />
0<br />
-503<br />
-14,859<br />
-15,362<br />
120 Annual Report 2008 <strong>Symrise</strong> AG